Biotech company Regeneron to buy bankrupt 23andMe for $256M

arstechnica.com/science/2025/05/biotech-company-regeneron-to-buy-bankrupt-23andme-for-256m

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing company running without interruption and uphold its privacy protection promises.
In its announcement of the acquisition, Regeneron assured 23andMe's 15 million…

This story appeared on arstechnica.com, 2025-05-19 22:59:23.816000.
The Entire Business World on a Single Page. Free to Use →